Effects of cilostazol on oxidative stress, systemic cytokine release, and spinal cord injury in a rat model of transient aortic occlusion

Annals of Vascular Surgery

Volumn 28, Issue 2, 2014, Pages 479-488

  Kurtoglu, Tunay ^a   Basoglu, Harun ^a   Ozkisacik, Erdem Ali ^a   Cetin, Nesibe Kahraman ^a   Tataroglu, Canten ^a   Yenisey, Cigdem ^a   Discigil, Berent ^a  

^a ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CILOSTAZOL; DIMETHYL SULFOXIDE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; AORTA OCCLUSION; ARTERIAL GAS; ARTICLE; BLOOD PH; BLOOD PRESSURE; BODY TEMPERATURE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; DRUG EFFECT; ELECTROSTIMULATION; ENZYME ACTIVITY; ERYTHROCYTE; HISTOPATHOLOGY; INFLAMMATION; LAPAROTOMY; LIPID PEROXIDATION; MALE; MOTOR PERFORMANCE; MYELITIS; NERVE CONDUCTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RAT MODEL; REPERFUSION; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA; VELOCITY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; AORTA, ABDOMINAL; BIOLOGICAL MARKERS; CELL SURVIVAL; CONSTRICTION; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; LIPID PEROXIDATION; MALE; MOTOR ACTIVITY; NEURAL CONDUCTION; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; SPINAL CORD; SPINAL CORD ISCHEMIA; TETRAZOLES; TIME FACTORS;

EID: 84893268930     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2013.08.005     Document Type: Article

References (54)

1. R.G. MacArthur, S.A. Carter, and J.S. Coselli et al. Organ protection during thoracoabdominal aortic surgery: rationale for a multimodality approach Semin Cardiothorac Vasc Anesth 9 2005 143 149
2. A.C. Sinha, and A.T. Cheung Spinal cord protection and thoracic surgery Curr Opin Anaesthesiol 23 2010 95 102
3. K. Hirose, K. Okajima, and Y. Taoka et al. Activated protein C reduces the ischemia/reperfusion-induced spinal cord injury in rats by inhibiting neutrophil activation Ann Surg 232 2000 272 280
4. A.E. Fiane, V. Videm, and P.S. Lingaas et al. Mechanism of complement activation and its role in the inflammatory response after thoracoabdominal aortic aneurysm repair Circulation 108 2003 849 856
5. M.B. Welborn, H.S. Oldenburg, and P.J. Hess et al. The relationship between visceral ischemia, proinflammatory cytokines, and organ injury in patients undergoing thoracoabdominal aortic aneurysm repair Crit Care Med 28 2000 3191 3197
6. G. Gong, L.B. Yuan, and L. Hu et al. Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1 Acta Pharmacol Sin 33 2012 11 18
7. A. Hasturk, B. Atalay, and T. CalIsaneller et al. Analaysis of serum pro-inflammatory cytokine levels after rat spinal cord ischemia/reperfusion injury and correlation with tissue damage Turk Neurosurg 19 2009 353 359
8. P.D. Smith, F. Puskas, and X. Meng et al. The evolution of chemokine release supports a bimodal mechanism of spinal cord ischemia and reperfusion injury Circulation 126 2012 110 117
9. S.J. Klebanoff, M.A. Vadas, and J.M. Harlan et al. Stimulation of neutrophils by tumor necrosis factor J Immunol 136 1986 4220 4225
10. Y. Taoka, K. Okajima, and K. Murakami et al. Role of neutrophil elastase in compression-induced spinal cord injury in rats Brain Res 799 1998 264 269
11. Y. Ikeda Antiplatelet therapy using cilostazol, a specific PDE3 inhibitor Thromb Haemost 82 1999 435 438
12. K. Schrör The pharmacology of cilostazol Diabetes Obes Metab 2 2002 14 19
13. T.M. Chapman, and K.L. Goa Cilostazol: a review of its use in intermittent caludication Am J Cardiovasc Drugs 2 2003 117 138
14. M. Sakurada, T. Yoshimoto, and T. Sekizawa et al. Vasculuprotective effect of cilastozol in aldosterone-induced hypertensive rats Hypertens Res 33 2010 229 235
15. W.S. Park, W.K. Jung, and D.Y. Lee et al. Cilostozol protects mice against endotoxin shock and attenuates LPS-induced cytokine expression in RAW 264.7 macrophages via MAPK inhibition and NF-kappaB inactivation: not involved in cAMP mechanisms Int Immunopharmacol 10 2010 1077 1085
16. F. Wang, M. Li, and L. Cheng et al. Intervention with cilostozol attenuates renal inflammation in streptozocin-induced diabetic rats Life Sci 83 2008 828 835
17. M. Yoshikawa, A. Suzumura, and T. Tamaru et al. Effects of phosphodiesterase inhibitors on cytokine production by microglia Mult Scler 5 1999 126 133
18. M.J. Kim, J.H. Lee, and S.Y. Park et al. Protection from apoptotic cell death by cilostazol, phosphodiesterase type III inhibitor, via c AMP-dependent protein kinase activation Pharmacol Res 54 2006 261 267
19. M.A. Sahin, B. Onan, and A. Guler et al. Cilostozol, a type III phosphodiesterase inhibitor, reduces ischemia/reperfusion-induced spinal cord injury Heart Surg Forum 14 2011 171 177
20. H. Iida, M. Iida, and M. Takenaka et al. Comparative effects of cilostazol and aspirin on the impairment of endothelium-dependent cerebral vasodilation caused by acute cigarette smoking in rats J Thromb Thrombolysis 29 2010 483 488
21. A. Ucak, B. Onan, and A. Güler et al. Rosuvastatin, a new generation 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, reduces ischemia/reperfusion-induced spinal cord tissue injury in rats Ann Vasc Surg 25 2011 686 695
22. I.M. Tarlov, and H. Klinger Spinal cord compression studies Arch Neurol Psychiat 71 1954 271 290
23. H. Basoglu, T. Kurtoglu, and N.K. Cetin et al. Assessment of in vivo spinal cord conduction velocity in rats in an experimental model of ischemic spinal cord injury Spinal Cord 51 2013 616 622
24. H. Okahawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 1979 351 358
25. H. Aebi Catalase H.U. Bergmeyer, Methods of enzymatic analysis 1974 Academic Press New York 673 677
26. Y. Sun, L.W. Oberley, and Y. Li A simple method for clinical assay of superoxide dismutase Clin Chem 34 1988 497 500
27. M. Boga, B. Discigil, and E.A. Ozkisacik et al. The combined effect of iloprost and N-acetylcysteine in preventing spinal cord ischemia in rabbits Eur J Vasc Endovasc Surg 31 2006 366 372
28. J.C. Papakostas, M.I. Matsagas, and I.K. Toumpoulis et al. Evolution of spinal cord injury in a porcine model of prolonged aortic occlusion J Surg Res 133 2006 159 166
29. E. Birben, U.M. Sahiner, and C. Sackesen et al. Oxidative stres and antioxidant defense Word Allergy Organ J 5 2012 9 19
30. C.M. Maier, and P.H. Chan Role of superoxide dismutases in oxidative damage and neurodegenerative disorders Neuroscientist 8 2002 323 334
31. M. Fujimura, T. Tominaga, and P.H. Chan Neuroprotective effect of an antioxidant in ischemic brain injury: involvement of neuronal apoptosis Neurocrit Care 2 2005 59 66
32. M. Valko, D. Leibfritz, and J. Moncol et al. Free radicals and antioxidants in normal physiological functions and human disease Int J Biochem Cell Biol 39 2007 44 84
33. E. Akcil, T. Tug, and Z. Doseyen Antioxidant enzyme activities and trace element concentrations in ischemia-reperfusion Biol Trace Elem Res 76 2000 13 17
34. F. Ozkan, Y. Senayli, and H. Ozyurt et al. Antioxidant effects of propofol on tourniquet-induced ischamia-reperfusion injury: an experimental study J Surg Res 176 2012 601 607
35. G. Bosco, Z.J. Yang, and J. Nandi et al. Effects of hyperbaric oxygen on glucose, lactate, glycerol and anti-oxidant enzymes in the skeletal muscle of rats during ischemia and reperfusion Clin Exp Pharmacol Physiol 34 2007 70 76
36. S. Savas, N. Delibas, and C. Savas et al. Pentoxifylline reduces biochemical markers of ischemia-reperfusion induced spinal cord injury in rabbits Spinal Cord 40 2002 224 229
37. T.Y. Yune, S.M. Lee, and S.J. Kim et al. Manganese superoxide dismutase induced by TNF-beta is regulated transcriptionally by NF-kappaB after spinal cord injury in rats J Neurotrauma 21 2004 1778 1794
38. R. Lin, G. Roseborough, and Y. Dong et al. DNA damage and repair system in spinal cord ischemia J Vasc Surg 37 2003 847 858
39. K. Hamann, and R. Shi Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury J Neurochem 111 2009 1348 1356
40. U. Jaffer, R.G. Wade, and T. Gourlay Cytokines in the systemic inflammatory response syndrome: a review HSR Proc Intensive Care Cardiovasc Anesth 2 2010 161 175
41. 2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord Ann Thorac Surg 72 2001 1245 1250
42. F. Simon, A. Scheuerle, and M. Gröger et al. Comparision of carbamylated erythropoietin-FC fusion protein and recombinant human erythropoietin during porcine aortic balloon occlusion-induced spinal cord ischemia/reperfusion injury Intensive Care Med 37 2011 1525 1533
43. K.W. Hong, J.H. Lee, and K.Y. Kima et al. Cilostozol: therapeutic potential against focal cerebral ischemic damage Curr Pharm Des 12 2006 565 573
44. W.K. Jung, D.Y. Lee, and C. Park et al. Cilostozol is anti-inflammatory in BV2 microglial cells by inactivating nuclear factor-kappaB and inhibiting mitogen-activated protein kinases Br J Pharmacol 159 2010 1274 1285
45. H.K. Shin, Y.K. Kim, and K.Y. Kim et al. Remnant lipoprotein particles induce apoptosis in endothelial cells by NAD (P)H oxidase-mediated production of superoxide and cytokines via lectin-like oxidized low-density lipoprotein receptor-1 activation: prevention by cilostazol Circulation 109 2004 1022 1028
46. J.H. Lee, G.T. Oh, and S.Y. Park et al. Cilostazol reduces atherosclerosis by inhibition of superoxide and tumor necrosis factor-alpha formation in low-density lipoprotein receptor -null mice fed high cholesterol J Pharmacol Exp Ther 313 2005 502 509
47. J.H. Lee, K.Y. Kim, and Y.K. Lee et al. Cilostazol prevents focal cerebral ischemic injury by enhancing casein kinase 2 phosphorylation and suppression of phosphatase and tensin homolog deleted from chromosome 10 phosphorylation in rats J Pharmacol Exp Ther 308 2004 896 903
48. J.M. Choi, H.K. Shin, and K.Y. Kim et al. Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats J Pharmacol Exp Ther 300 2002 787 793
49. S.L. Bramer, W.P. Forbes, and S. Mallikaarjun Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease Clin Pharmacokinet 37 1999 1 11
50. S. Manickavasagam, Y. Ye, and Y. Lin et al. The cardioprotective effect of a statin and cilostazol combination: relationship to Akt and endothelial nitric oxide synthase activation Cardiovasc Drugs Ther 21 2007 321 330
51. R. Ohba, M. Otaka, and M. Odashima et al. Effect of cilostazol, a selective type-III phosphodiesterase inhibitor, on water-immersion stress-induced gastric mucosal injury in rats J Gastroenterol 41 2006 34 40
52. H. Ito, A. Hashimoto, and Y. Matsumoto et al. Cilostazol, a phosphodiesterase inhibitor, attenuates photothrombotic focal ischemic brain injury in hypertensive rats J Cereb Blood Flow Metab 30 2010 343 351
53. P.K. Stys White matter injury mechanisms Curr Mol Med 2 2004 113 130
54. M. Sekiguchi, Y. Aoki, and S. Konno et al. The effects of cilostazol on nerve conduction velocity and blood flow: acute and chronic cauda equine compression in a canine model Spine (Phila Pa 1976) 33 2008 2605 2611